Grants Search Results

This institution is a member of a research consortium which is being funded by St. Baldrick's: the New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: the Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: the Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: the Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium on Pediatric Myelodysplastic Syndromes and Ribosome Dysfunction. For a description of this project, see the consortium grant made to the lead institution: the Feinstein Institute for Medical Research, Manhasset, NY.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium on Pediatric Myelodysplastic Syndromes and Ribosome Dysfunction. For a description of this project, see the consortium grant made to the lead institution: the Feinstein Institute for Medical Research, Manhasset, NY.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium on Pediatric Myelodysplastic Syndromes and Ribosome Dysfunction. For a description of this project, see the consortium grant made to the lead institution: the Feinstein Institute for Medical Research, Manhasset, NY.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium on Pediatric Myelodysplastic Syndromes and Ribosome Dysfunction. For a description of this project, see the consortium grant made to the lead institution: the Feinstein Institute for Medical Research, Manhasset, NY.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Acute Lymphoblastic Leukemia Commitee of the Children's Oncology Group. For a description of this project, "Recurrence testing of new genomic lesions in childhood ALL," see the consortium grant made to the lead institution: the University of California, San Francisco, San Francisco, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Acute Lymphoblastic Leukemia Commitee of the Children's Oncology Group. For a description of this project, "Recurrence testing of new genomic lesions in childhood ALL," see the consortium grant made to the lead institution: the University of California, San Francisco, San Francisco, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Acute Lymphoblastic Leukemia Commitee of the Children's Oncology Group. For a description of this project, "Recurrence testing of new genomic lesions in childhood ALL," see the consortium grant made to the lead institution: the University of California, San Francisco, San Francisco, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Acute Lymphoblastic Leukemia Commitee of the Children's Oncology Group. For a description of this project, "Recurrence testing of new genomic lesions in childhood ALL," see the consortium grant made to the lead institution: the University of California, San Francisco, San Francisco, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick"s: the Testicular Cryopreservation Consortium (TCC). For a description of this project, "Translating the Science of Testicular Tissue Cryopreservation," see the consortium grant made to the lead institution: the Children's Hospital of Philadelphia, Philadelphia, PA.

This institution is a member of a research consortium which is being funded by St. Baldrick"s: the Testicular Cryopreservation Consortium (TCC). For a description of this project, "Translating the Science of Testicular Tissue Cryopreservation," see the consortium grant made to the lead institution: the Children's Hospital of Philadelphia, Philadelphia, PA.

This institution is a member of a research consortium, the International Neuroblastoma Risk Group (INRG) Task Force, which is named for the “Just Do It…and be done with it” St. Baldrick’s Hero Fund created to celebrate the courage of cancer kids through treatment and the support of their family and friends. For a description of this project, see the consortium grant made to the lead institution: the University of Chicago, Chicago, IL., IL.

This institution is a member of a research consortium, the International Neuroblastoma Risk Group (INRG) Task Force, which is named for the “Just Do It…and be done with it” St. Baldrick’s Hero Fund created to celebrate the courage of cancer kids through treatment and the support of their family and friends. For a description of this project, see the consortium grant made to the lead institution: the University of Chicago, Chicago, IL.

This institution is a member of a research consortium, the International Neuroblastoma Risk Group (INRG) Task Force, which is named for the “Just Do It…and be done with it” St. Baldrick’s Hero Fund created to celebrate the courage of cancer kids through treatment and the support of their family and friends. For a description of this project, see the consortium grant made to the lead institution: the University of Chicago, Chicago, IL.

This institution is a member of a research consortium, the Childhood and Adolescent Lymphoma Cell Therapy Consortium (CALCTC), which is named for Markit, Ltd. whose 24-hour head-shaving events worldwide have raised over $2.2 million since 2007 to fund life-saving research through the St. Baldrick’s Foundation. For a description of this project, see the consortium grant made to the lead institution: the New York Medical College - Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY.

This institution is a member of a research consortium, the Childhood and Adolescent Lymphoma Cell Therapy Consortium (CALCTC), which is named for Markit, Ltd. whose 24-hour head-shaving events worldwide have raised over $2.2 million since 2007 to fund life-saving research through the St. Baldrick’s Foundation. For a description of this project, see the consortium grant made to the lead institution: the New York Medical College - Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY.

This institution is a member of a research consortium, the Childhood and Adolescent Lymphoma Cell Therapy Consortium (CALCTC), which is named for Markit, Ltd. whose 24-hour head-shaving events worldwide have raised over $2.2 million since 2007 to fund life-saving research through the St. Baldrick’s Foundation. For a description of this project, see the consortium grant made to the lead institution: the New York Medical College - Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY.

This institution is a member of a research consortium, the Childhood and Adolescent Lymphoma Cell Therapy Consortium (CALCTC), which is named for Markit, Ltd. whose 24-hour head-shaving events worldwide have raised over $2.2 million since 2007 to fund life-saving research through the St. Baldrick’s Foundation. For a description of this project, see the consortium grant made to the lead institution: the New York Medical College - Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY.